- 2024-08-20 01:44抑制剂AI-10-49|AI-10-49|1256094-72-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂AGI-5198|AGI-5198|1355326-35-0|Adamas life|≥98%（以实测数值为准）|BR|500mg
- 2024-08-20 01:44抑制剂AI-10-47|AI-10-47|1256094-31-1|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:44抑制剂AI-10-47|AI-10-47|1256094-31-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂AI-10-47|AI-10-47|1256094-31-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂Agerafenib|Agerafenib|1188910-76-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂Agerafenib|Agerafenib|1188910-76-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂AGI-5198|AGI-5198|1355326-35-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:44抑制剂AGI-5198|AGI-5198|1355326-35-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂AG-636|AG-636|1623416-31-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:44抑制剂AG-636|AG-636|1623416-31-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂AG-636|AG-636|1623416-31-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂Agerafenib|Agerafenib|1188910-76-0|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:44抑制剂AG1557|AG1557|189290-58-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂AG1557|AG1557|189290-58-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂AG1557|AG1557|189290-58-2|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:44抑制剂AG14361|AG14361|328543-09-5|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:44抑制剂AG14361|AG14361|328543-09-5|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:44抑制剂AG14361|AG14361|328543-09-5|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:44抑制剂Afimetoran|Afimetoran|2171019-55-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
